ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive”

June 11, 2010

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

July 30, 2004

New Therapeutic Approaches Improve Palliative Care

June 27, 2003

Cooperative Group Chairman Unhappy Over Exclusion From Funding at Recommended Levels

December 2, 1983

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979